{"data":[{"accessionNo":"0002012383-26-003904","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc.","ticker":"HRMY","cusip":"413197104","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":7361888,"percentOfClass":12.6,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0002100121-26-000926","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings Inc","ticker":"HRMY","cusip":"413197104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":2943383,"percentOfClass":5.08,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0002012383-26-002586","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc.","ticker":"HRMY","cusip":"413197104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":6525663,"percentOfClass":11.3,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0000102909-26-001452","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings Inc","ticker":"HRMY","cusip":"413197104","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0000315066-26-000449","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001802665","issuerName":"HARMONY BIOSCIENCES HOLDINGS INC","ticker":"HRMY","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3112812.16,"percentOfClass":5.4,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0000315066-26-000449","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001802665","issuerName":"HARMONY BIOSCIENCES HOLDINGS INC","ticker":"HRMY","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3112812.16,"percentOfClass":5.4,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Antonio J. Gracias","reportingCik":null,"personType":"IN","sharesOwned":1831327,"percentOfClass":3.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Juan A. Sabater","reportingCik":null,"personType":"IN","sharesOwned":1392250,"percentOfClass":2.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Valor Equity Associates IV L.P.","reportingCik":null,"personType":"HC","sharesOwned":1268204,"percentOfClass":2.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Valor Equity Capital IV LLC","reportingCik":null,"personType":"HC","sharesOwned":1268204,"percentOfClass":2.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Valor Management L.P.","reportingCik":null,"personType":"HC","sharesOwned":1297701,"percentOfClass":2.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Valor Equity Partners IV L.P.","reportingCik":null,"personType":"PN","sharesOwned":766836,"percentOfClass":1.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Valor Equity Partners IV-B L.P.","reportingCik":null,"personType":"PN","sharesOwned":396651,"percentOfClass":0.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Valor Equity Partners IV-A L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0001213900-25-111024","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001802665","issuerName":"Harmony Biosciences Holdings, Inc","ticker":"HRMY","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Valor IV Pharma Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0000315066-25-002757","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001802665","issuerName":"HARMONY BIOSCIENCES HOLDINGS INC","ticker":"HRMY","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3846972.08,"percentOfClass":6.7,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"},{"accessionNo":"0000315066-25-002757","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001802665","issuerName":"HARMONY BIOSCIENCES HOLDINGS INC","ticker":"HRMY","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3846972.08,"percentOfClass":6.7,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy"}],"updatedAt":"2026-11-04T08:00:13.417Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/hrmy","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}